Recombinant advanced glycation end product receptor pharmacokinetics in normal and diabetic rats

Molecular Pharmacology

Volumn 52, Issue 1, 1997, Pages 54-62

  Renard, C ^a,b   Chappey, O ^a   Wautier, M P ^a   Nagashima, M ^c   Lundh, E ^c   Morser, J ^c   Zhao, L ^c   Schmidt, A M ^d   Scherrmann, J M ^b   Wautier, J L ^a,e  

^a HÔPITAL LARIBOISIÈRE   (France)

^b HÔPITAL FERNAND WIDAL   (France)

^c BAYER AG   (Germany)

^d New York Presbyterian Columbia University Medical Center   (United States)

^e INSTITUT NATIONAL DE LA TRANSFUSION SANGUINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; GLYCOSYLATED PROTEIN; INULIN; RECEPTOR; RECOMBINANT PROTEIN;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETIC ANGIOPATHY; DRUG DISTRIBUTION; DRUG EFFECT; DRUG ELIMINATION; DRUG HALF LIFE; HUMAN; HUMAN CELL; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PERMEABILITY; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES;

EID: 0030838112     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.52.1.54     Document Type: Article

References (22)

1. References 1. Ruderman, N., J. Williamson, and M. Brownlee. Glucose and diabetic vascular disease. FASEB J. 6:2905-2914 (1992).
2. Schmidt, A. M., O. Hori, J. Brett, S.-D. Yan, J.-L. Wautier, and D. Stern. Cellular receptor for AGEs. Arterioscler. Thromb. 14:1521-1528 (1994).
3. Chappey, O., C. Dosquet, M.-P. Wautier, and J.-L. Wautier. Advanced glycation end products, oxidant stress and vascular lesions: a review. Eur. J. Clin. Invest. 27:97-108 (1997).
4. Neeper, M., A.-M. Schmidt, J. Brett, S.-D. Yan., F. Wang, Y.-C. Pan, K. Elliston, D. Stern, and A. Shaw. Cloning and expression of RAGE: a cell surface receptor for advanced glycosylation end products of proteins. J. Biol. Chem. 267:14998-15004 (1992).
5. Brett, J., A.-M. Schmidt, Y.-S. Zou, E. Weidman, D. Pinsky, M. Neeper, C. Przysiecki, A. Shaw, A. Amigheli, and D. Stern. Survey of the distribution of a newly characterized receptor for advanced glycosylation end products in tissues. Am. J. Pathol. 143:1699-1712 (1993).
6. Wautier, J.-L., M.-P. Wautier, A.-M. Schmidt, G.-M. Anderson, O. Hori, C. Zoukourian, L. Capron, O. Chappey, J. Brett, P.-J. Guillausseau, and D. Stern. AGEs on the surface of diabetic erythrocytes bind to vessels wall via a specific receptor inducing oxidant stress in the vasculature: a link between surface associated AGEs and diabetic complications. Proc. Natl. Acad. Sci. USA 91:8807-8811 (1994).
7. Wautier, J.-L., C. Zoukourian, O. Chappey, M.-P. Wautier, P.-J. Guillausseau, R. Cao, O. Hori, D. Stern, and A.-M. Schmidt. Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy: soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats. J. Clin. Invest. 97:238-243 (1996).
8. Maniatis, T., E. Fritsch, and J. Sambrook. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor University Press, Cold Spring Harbor, NY (1982).
9. Sanger, F., S. Nicklen, and A.-R. Coulson. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74:5463-5467 (1977).
10. Fraker, P.-J., and J.-C. Speck. Protein and cell membrane iodination with a sparingly soluble chloroamide 1,3,4,6-tetrachloro-3a,6a-diphenylglycouril. Biochem. Biophys. Res. Commun. 80:849-857 (1978).
11. Albelda, S., P.-M. Sampson, F.-R. Haselton, J.-M. McNiff, S.-M. Meller, S.-K. Williams, and A.-P. Fishman. Permeablity characteristics of cultured endothelial cells monolayers. J. Appl. Physiol. 64:308-322 (1988).
12. Williamson, J.-R., K. Chang, R.-G. Tilton, C. Prater, J.-R. Jeffrey, C. Weigel, and W.-R. Sherman. Increased vascular permeability in spontaneously diabetic BB/W rats and in rats with mild versus severe streptozotocin-induced diabetes. Diabetes 36:813-821 (1987).
13. Yagi, K. Lipid peroxides and human diseases. Chem. Phys. Lipids 45:337-351 (1987).
14. Ebling, W., D. Russel Wada, and D. Stanski. From piecewise to full physiologic pharmacokinetic modeling: applied to thiopental disposition in the rat. J. Pharmacokinet. Biopharm. 22:259-292 (1994).
15. Gibaldi, M., and D. Perrier. Pharmacokinetics. Dekker, New York (1982).
16. Rowland, M., and T.-N. Tozer. Clinical Pharmacokinetics: Concepts and Applications. 2nd Ed. Lea & Febiger, Philadelphia (1989).
17. Maack, T., V. Johnson, S. Kau, J. Figueiredo, and D. Sigulem. Renal filtration, transport, and metabolism of low-molecular-weight proteins: a review. Kidney Int. 16:251-270 (1979).
18. Schmidt, A. M., M. Hasu, D. Popov, J.-H. Zhang, J. Chen, S.-D. Yan, J. Brett, R. Cao, K. Kuwabara, G. Costache, N. Simionescu, M. Simionescu, and D. Stern. Receptor for AGEs has a central role in vessel wall interactions and gene activation in response to AGE proteins. Proct. Natl. Acad. Sci. USA 91:8807-8811 (1994).
19. Smith, D., R. Byrn, S. Masters, T. Gregory, J. Groopman, and D. Capon. Blocking of HIV-1 infectivity by a soluble, secreted form of the CD4 antigen. Science (Washington D. C.) 238:1704-1707 (1987).
20. Jacobs, C., P. Baker, E. Roux, K. Picha, B. Toivola, S. Waugh, and M. Kennedy. Experimental autoimmune encephalomyelitis is exacerbated by IL-1 alpha and suppressed by soluble IL-1 receptor. J. Immunol. 146: 2983-2989 (1991).
21. Hori, O., J. Brett, T. Slattery, R. Cao, J. Zhang, J.-X. Chen, M. Nagashima, E.-R. Lundh, S. Vijay, D. Nitecki, J. Morser, D. Stern, and A.-M. Schmidt. The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. J. Biol. Chem. 270:25752-25761 (1995).
22. Yan, S.-D., X. Chen, J. Fu, M. Chen, H. Zhu, A. Roher, T. Slattery, L. Zhao, M. Nagashima, J. Morser, A. Migheli, P. Nawroth, D. Stern, and A.-M. Schmidt. RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease. Nature (Lond.). 382:685-691 (1996).